Progressive Supranuclear Palsy (PSP) Completed Phase 1 Trials for Gosuranemab (DB15376)

Also known as: Progressive Supranuclear Palsy / Steele-Richardson-Olszewski syndrome / Supranuclear Palsy, Progressive

IndicationStatusPhase
DBCOND0063930 (Progressive Supranuclear Palsy (PSP))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02460094Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear PalsyTreatment